Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
First mechanism GLP-1
A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults
But certain health conditions or medicines can cause low carnitine levels in the body (carnitine deficiency)
GLP-1 medications work by overriding the body natural weight regulation system, which is powerful and persistent
Discussion The patient in this case report presented with a complex constellation of neurological symptoms, including progressive limb weakness, sensory disturbances, blurred vision, and acute encephalopathy, against a background of multiple chronic medical conditions and recent significant weight loss associated with semaglutide use
The European Medicines Agency (EMA) began investigating this potential side effect in July 2023
